Bristol-Myers Squibb Co BMY:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:04 AM EST
62.15quote price arrow down-0.46 (-0.73%)
Volume
1,838
Close
62.61quote price arrow down-0.93 (-1.46%)
Volume
12,601,391
52 week range
53.22 - 69.75
Loading...
  • Open63.18
  • Day High63.42
  • Day Low61.19
  • Prev Close62.61
  • 52 Week High69.75
  • 52 Week High Date08/23/21
  • 52 Week Low53.22
  • 52 Week Low Date11/30/21

Key Stats

  • Market Cap138.972B
  • Shares Out2.22B
  • 10 Day Average Volume13.45M
  • Dividend2.16
  • Dividend Yield3.45%
  • Beta0.58
  • YTD % Change0.42

KEY STATS

  • Open63.18
  • Day High63.42
  • Day Low61.19
  • Prev Close62.61
  • 52 Week High69.75
  • 52 Week High Date08/23/21
  • 52 Week Low53.22
  • 52 Week Low Date11/30/21
  • Market Cap138.972B
  • Shares Out2.22B
  • 10 Day Average Volume13.45M
  • Dividend2.16
  • Dividend Yield3.45%
  • Beta0.58
  • YTD % Change0.42

RATIOS/PROFITABILITY

  • EPS (TTM)-2.40
  • P/E (TTM)-26.06
  • Fwd P/E (NTM)8.04
  • EBITDA (TTM)20.50B
  • ROE (TTM)-12.37%
  • Revenue (TTM)45.468B
  • Gross Margin (TTM)79.00%
  • Net Margin (TTM)-11.84%
  • Debt To Equity (MRQ)120.23%

EVENTS

  • Earnings Date02/04/2022
  • Ex Div Date01/06/2022
  • Div Amount0.54
  • Split Date-
  • Split Factor-

Content From Our Affiliates

Related Video

VIDEO9:3909:39
Dell, Bristol-Myers Squibb and Meta are today's picks: Pro Market Movers Jan. 10

Profile

MORE
Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Its pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small...
Giovanni Caforio M.D.
Chairman of the Board, Chief Executive Officer
David Elkins
Executive Vice President and Chief Financial Officer Member of the Leadership Team
Elizabeth Mily
Executive Vice President - Strategy and Business Development, Member of the Leadership Team
Louis Schmukler
Executive Vice President, President - Global Product Development and Supply, Member of the Leadership Team
Sandra Leung
Executive Vice President, General Counsel, Member of the Leadership Team
Address
430 E 29th St Fl 14
New York, NY
10016-8367
United States

Top Peers

SYMBOLLASTCHG%CHG
SNY
Sanofi SA
50.84-0.40-0.78%
GSK
GlaxoSmithKline PLC
44.38-0.72-1.60%
NVS
Novartis AG
85.13UNCHUNCH
AMGN
Amgen Inc
226.08-1.64-0.72%
MRK
Merck & Co Inc
78.83-1.15-1.44%